000 | 02084 a2200625 4500 | ||
---|---|---|---|
005 | 20250513183207.0 | ||
264 | 0 | _c19990615 | |
008 | 199906s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNielsen, E O | |
245 | 0 | 0 |
_aSPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cJun 1999 |
||
300 |
_a1492-501 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCerebral Cortex _xphysiology |
650 | 0 | 4 | _aElectroshock |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aGlycine _xmetabolism |
650 | 0 | 4 |
_aIsoquinolines _xchemistry |
650 | 0 | 4 |
_aKainic Acid _xmetabolism |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 |
_aPipecolic Acids _xpharmacokinetics |
650 | 0 | 4 |
_aPyrroles _xchemistry |
650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, AMPA _xantagonists & inhibitors |
650 | 0 | 4 |
_aSeizures _xphysiopathology |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aTetrahydroisoquinolines |
650 | 0 | 4 |
_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid _xmetabolism |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
700 | 1 | _aVarming, T | |
700 | 1 | _aMathiesen, C | |
700 | 1 | _aJensen, L H | |
700 | 1 | _aMoller, A | |
700 | 1 | _aGouliaev, A H | |
700 | 1 | _aWätjen, F | |
700 | 1 | _aDrejer, J | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 289 _gno. 3 _gp. 1492-501 |
|
999 |
_c10295351 _d10295351 |